GL1X · GenesisL1 explorer

MolNFT v1 · #167789 · protein

Mycobacterium tuberculosis dihydrofolate reductase in complex with 6- methyl-5-(4-phenylthiazol-2-yl)-2- (TRIFLUOROMETHYL)NICOTINIC acid (fragment 10)

6VVB: “Mycobacterium tuberculosis dihydrofolate reductase in complex with 6- methyl-5-(4-phenylthiazol-2-yl)-2…”. X-ray diffraction, 2 ligands (RQ4, NAP), 2 pockets (best druggability 0.75). MolNFT v1 #167789 on GenesisL1: 3D structure…

PDB
6VVB
Type
protein
Length
160 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydrofolate reductase
EC
1.5.1.3
UniProt
P9WNX1
Ligands
RQ4, NAP
Pockets
2 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 21% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydrofolate reductase (EC 1.5.1.3)protein16021% helix, 34% strandP9WNX1

Ligands and binding sites

  • RQ4 · 6-methyl-5-(4-phenyl-1,3-thiazol-2-yl)-2-(trifluoromethyl)pyridine-3-carboxylic acid · ligand · chains A
  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • P33 · 3,6,9,12,15,18-hexaoxaicosane-1,20-diol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16330.750.8149RQ4, NAP
2550.310.7510empty

Compared structures

  • 6VVB · Mycobacterium tuberculosis dihydrofolate reductase in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • P9WNX1 · AlphaFold monomer V2.0 prediction for dihydrofolate reductase (P9WNX1) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.